文献速递类风湿关节炎

类风湿关节炎心肌炎症与疾病活动相关:FDG PET-CT研究

Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2019-02-28

本研究对119例无已知心血管疾病的类风湿关节炎患者行心脏FDG PET-CT,发现39%存在视觉可辨心肌FDG摄取,18%定量异常。校正混杂后,CDAI≥10者SUVmean较低活动组高31%(P=0.005);纵向亚组8例DMARD升级后6个月SUVmean从4.50降至2.30,同期CDAI从23降至12。

要点

  • RA患者亚临床心肌炎症常见,FDG PET-CT可视觉和定量评估。
  • 中高疾病活动度(CDAI≥10)与心肌SUVmean升高独立相关。
  • DMARD升级后心肌FDG摄取随疾病活动度下降而降低。

核心结论

  • RA患者亚临床心肌炎症常见,与RA疾病活动度相关,并可能随RA治疗而减轻。

研究设计与样本

  • 横断面研究纳入119例无已知心血管疾病的RA患者行心脏FDG PET-CT,另设27例非RA参照组定义定量异常阈值。
  • 纵向亚组8例需升级DMARD治疗者在6个月后复查FDG PET-CT。

主要发现

  • 119例RA患者中46例(39%)视觉评估见FDG摄取,21例(18%)定量心肌FDG摄取异常(SUVmean≥3.10单位)。
  • 校正潜在混杂后,CDAI≥10者SUVmean较低CDAI者高31%(P=0.005)。
  • 使用非TNF靶向生物制剂者校正SUVmean较传统非生物DMARD者低26%(P=0.029)。
  • 纵向亚组8例6个月内SUVmean从4.50单位降至2.30单位,同期平均CDAI从23降至12。

关键数值与推荐

  • 定量异常心肌FDG摄取定义为SUVmean≥3.10单位,即27例非RA参照组均值2个标准差以上。
  • 疾病活动度以CDAI评分分层:≥10为中高活动度,低于10为低活动度或缓解。

临床怎么用

  • 对RA患者应关注疾病活动度控制,中高活动度者可能存在亚临床心肌炎症。
  • FDG PET-CT可用于评估RA患者亚临床心肌炎症,但需结合视觉与定量SUVmean判断。
  • 升级DMARD治疗可能降低心肌FDG摄取,但需进一步纵向研究验证对心衰风险的影响。

局限性

  • 纵向亚组样本量仅8例,治疗相关变化的证据有限。
  • 定量异常阈值基于27例非RA参照组,外推需谨慎。
  • 未来需纵向研究评估心肌炎症降低是否减少RA心衰风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the prevalence and correlates of subclinical myocardial inflammation in patients with rheumatoid arthritis (RA). METHODS: RA patients (n = 119) without known cardiovascular disease underwent cardiac 18-fluorodeoxyglucose (FDG) positron emission tomography with computed tomography (PET-CT). Myocardial FDG uptake was assessed visually and measured quantitatively as the standardized uptake value (SUV). Multivariable linear regression was used to assess the associations of patient characteristics with myocardial SUVs. A subset of RA patients who had to escalate their disease-modifying antirheumatic drug (DMARD) therapy (n = 8) underwent a second FDG PET-CT scan after 6 months, to assess treatment-associated changes in myocardial FDG uptake. RESULTS: Visually assessed FDG uptake was observed in 46 (39%) of the 119 RA patients, and 21 patients (18%) had abnormal quantitatively assessed myocardial FDG uptake (i.e., mean of the mean SUV [SUVmean ] ≥3.10 units; defined as 2 SD above the value in a reference group of 27 non-RA subjects). The SUVmean was 31% higher in patients with a Clinical Disease Activity Index (CDAI) score of ≥10 (moderate-to-high disease activity) as compared with those with lower CDAI scores (low disease activity or remission) (P = 0.005), after adjustment for potential confounders. The adjusted SUVmean was 26% lower among those treated with a non-tumor necrosis factor-targeted biologic agent compared with those treated with conventional (nonbiologic) DMARDs (P = 0.029). In the longitudinal substudy, the myocardial SUVmean decreased from 4.50 units to 2.30 units over 6 months, which paralleled the decrease in the mean CDAI from a score of 23 to a score of 12. CONCLUSION: Subclinical myocardial inflammation is frequent in patients with RA, is associated with RA disease activity, and may decrease with RA therapy. Future longitudinal studies will be required to assess whether reduction in myocardial inflammation will reduce heart failure risk in RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Amigues I, Tugcu A, Russo C, et al. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol. 2019. PMID: 30407745. doi:10.1002/art.40771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。